MITF and neoplasm: Combining fate mapping with live imaging, immunohistochemistry (IHC) and MIHC, we provide direct evidence for the contribution of cells at the MRD site to tumour recurrence, whilst simultaneously demonstrating their MITF-independent to Mitfa+ cell state shift.